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Polychlorinated biphenyls (PCBs) and 1,1-
bis(4-chlorophenyl)-2,2-dichloroethene
(p,p'-DDE), a metabolite of the pesticide
DDT, are well-known pollutants that have
been found in many environmental matri-
ces and in humans (1). The industrial use of
PCBs has ceased in most countries, but
objects containing these compounds are still
employed and pollution may continue for a
long time, e.g., from electronic equipment
and building materials. DDT was a com-
monly used insecticide in the 1940s-1960s.
In Sweden and many other industrialized
countries, the usage ofDDT was banned in
the early 1970s and, consequently, the lev-
els have decreased in these areas. However,
DDT is still used in large quantities in
countries where malaria is a serious problem
(2,3). Due to the persistency ofDDT com-
pounds and the long-distance atmospheric
transportation, the residue levels ofthe pes-
ticide in the Western countries will proba-
bly be long-lasting.
In the metabolism of chlorinated
biphenyls (CBs) and p,p'-DDE, corre-
sponding methylsulfonyl (MeSO2) metabo-
lites can be formed via the mercapturic acid
pathway (MAP) (4,5). The CBs with
nonchlorinated, adjacent 3 and 4 positions
and chlorine atoms in the 2, 5 or 2, 3, 6
positions ofthe same ring have been shown
to form metabolites with the MeSO2-group
in position 3 or 4 (6). The MeSO2-group
location in MeSO2-DDEs is limited to
either the 2 or the 3 position. The forma-
tion ofmethylsulfonyl metabolites of, e.g.,
CBs with vicinal hydrogen atoms, is initi-
ated by cytochrome P450-mediated oxida-
tion to arene oxide intermediates. Arene
oxides with chlorine atoms on both sides
ofthe 3,4-positions readily react with glu-
tathione in position 3 or 4. The glu-
tathione conjugates are transformed via
MAP to cystein conjugates, which are
cleaved by C-S lyase to thiol-substituted
CBs (4,5). These are methylated by adeno-
syl-methionine to methyl sulfides, which
then are oxidized to methyl sulfones via an
intermediate formation of methylsulfinyl-
CBs (4,5). Methylsulfonyl metabolites of
CBs andp,p'- DDE are persistent and, due
to their lipophilic character, they accumu-
late in adipose tissue (6-8). They may also
have specific protein-binding properties
that cause them to be retained in the body,
e.g., 3-MeSO2-DDE in adrenal tissue
(9,10) and certain MeSO2-CBs in lung,
kidney, and uterine fluid (11-13), as
demonstrated in experimental animals.
In environmental samples, MeSO2-CBs
and MeSO2-DDEs were first identified in
seal blubber from the Baltic(14); since then,
such metabolites have been found in several
species of animals (6) and in humans
(7,8,15). Recently, MeSO2-CBs and
MeSO2-DDEs were determined in Swedish
mother's milk (16) and MeSO2-CBs were
determined in human bloodplasma (17).
The toxicological significance of
MeSO2-CBs has not yet been clarified, but
recently certain 3-MeSO2-CBs were report-
ed to be potent inducers ofhepatic enzymes
that are related to toxic effects (18,19). 3-
MeSO2-DDE is a potent toxicant for the
adrenal cortex, e.g., in mice (9) and proba-
bly also in humans, as suggested by in vitro
studies, showing that 3-MeSO2-DDE is
bioactivated to a tissue-binding metabolite
by the human adrenal gland (10).
The occurrence of MeSO2-CBs and
MeSO2-DDEs in wildlife and human sam-
ples and the demonstrated accumulation of
certain MeSO2-CBs and MeSO2-DDEs in
specific tissues of mammals have made the
investigation of these compounds impor-
tant. The knowledge of accumulation and
distribution of methylsulfonyl metabolites
of aromatic organochlorine pollutants in
humans is scarce. Therefore, in the present
study we have determined MeSO2-CBs and
MeSO2-DDEs together with CBs andp,p'-
DDE in adipose tissue and liver from
human subjects.
Materials and Methods
Sample description. Samples ofadipose tis-
sue from the abdominal region and ofliver
were collected at autopsy of five men and
two women (Swedish) who had suffered
sudden death. The age of the men ranged
from 53 to 80 years (mean 68 years, median
68 years) and the age ofthe women were 47
and 62 years. The samples were frozen
immediately after collection, kept at -200C,
and thawed onlybefore analysis.
Chemicals. 3-Methylsulfonyl-4-methyl-
2',3',4',5,5'-pentachlorobiphenyl
(MeSO2-IS) was used as an internal stan-
dard. Individual MeSO2-CBs, 3-MeSO2-
DDE, and MeSO2-IS were gifts from Ake
Bergman and were synthesized as described
elsewhere (20-22). Structures and abbrevia-
tions of MeSO2-CBs are given in Table 1.
[4-14C]Cholesterol (14C-cholesterol) and
1,2-di[1_14C]palmitoyl-sn-3-phosphatidyl-
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choline (14C-phosphatidyl-choline) were
purchased from Amersham International
(Buckinghamshire, UK) and were dissolved
in toluene. Organic solvents were of high
purity and redistilled prior to use (24).
Water was deionized and purified with a
Milli-Q cartridge system (Millipore,
Bedford, MA). Formic acid (98-100%)
(Riedel de Haen, Seelze, Germany) was
extracted twice with hexane (50 ml hexane to
100 ml formic acid). Glassware was washed
thoroughly, heated overnight at 280°C, and
rinsed with hexane prior to use (24).
Extraction, lipid determination, and
preliminary purification. Liver (-3g) or
adipose tissue (-0.5 g) was weighed into a
100-ml test tube with a polytetrafluoroeth-
ylene (PTFE)-lined screw cap. Internal
standard (50 pl of 41.4 pg MeSO2-IS/Pl
hexane) was added and the sample was
homogenized with an Ultra Turrax
homogenizer Uanke & Kunkel, Germany)
and extracted with hexane/2-propanol (20
ml, 3/2 v/v). The homogenat(
trifuged at 3500 rpm for 10 m
organic solvent phase was coll
round-bottomed flask. The extr;
cedure was repeated once with
propanol (20 ml, 3/2 v/v) and
hexane (20 ml). The pooled org;
were evaporated under reduced
35°C. The residue was dried in a
with silica gel at room tempei
then weighed. The residue was d
hexane and transferred to
Erlenmeyer flask (samples conta
than 0.3 g lipids were diluted M
and an aliquot of the sample w;
the Erlenmeyer flask). The volt
sample solution was adjusted to
hexane. 2-Propanol (8 ml) and f
(0.5 ml) were mixed with the sa
tion, and 6 g Lipidex 5000
Instruments, Downers Grove, II
added. Lipids and lipophilic con
the sample were transferred into
Table 1. Concentrations (ng/g lipids) of MeSO2-CBs and MeSO2-DDEs in adipose and livertissue
subjects (n=7)
MeSO2-CB Cl substitution
3-498 2,2',4',5
4-49 2,2',4',5
3-52 2,2',5,5'
4-52 2,2',5,5'
3-64 2,4',5,6
4-64 2,3,4',6
3-70 2,3',4',5
4-70 2,3',4',5
3-87 2,2',3',4',5
4-87 2,2',3',4',5
3-91 2,2',4',5,6
4-91 2,2',3,4',6
3-101 2,2',4',5,5'
4-101 2,2',4',5,5'
3-110 2,3',4',5,6
4-110 2,3',4',5,6
3-132 2,2',3',4',5,6
4-132 2,2',3,3',4',6
3-141 2,2',3',4',5,5'
4-141 2,2',3',4',5,5'
3-149 2,2',4',5,5',6
4-149 2,2',3,4',5',6
3-174 2,2',3',4',5,5',6
4-174 2,2',3,3',4',5',6
Sum of MeSO2-CBs
2-MeSO2-DDE
3-MeSO2-DDE
Sum of MeSO2-DDEs
2-MeSO2-DDE/
3-MeSO2-DDE
p,p'-DDE
Sum of CBs
CB-153
Sum of MeSO2-DDEs/
p,p'-DDE
Sum of MeSO2-CBs/
CBs
Sum of MeSO2-CBs/
CB-153
Median
0.02
0.13
<0.01
<0.01
0.03
<0.01
0.04
<0.01
0.07
0.82
<0.01
0.01
0.17
0.40
<0.01
<0.01
0.07
0.04
0.03
0.19
0.33
0.71
<0.03
<0.03
2.93
0.07
1.39
1.47
0.04
707
977
275
0.002
0.004
0.012
Adipose
Range
0.01-0.09
0.06-0.47
<0.01
<0.01
0.02-0.12
<0.01-0.03
0.02-0.12
<0.01
0.04-0.35
0.48-3.59
<0.01
<0.01-0.10
0.07-0.85
0.21-2.61
<0.01
<0.01
<0.02-0.29
<0.02-0.29
<0.02-0.19
0.12-0.91
0.17-2.81
0.41-5.06
<0.03-0.13
<0.03-0.05
2.02-8.96
<0.02-0.38
0.12-8.88
0.12-9.26
0-0.09
121-1394
492-1993
136-586
0.001-0.007
Median
0.05
0.11
<0.01
<0.01
0.05
<0.01
0.05
0.04
0.83
1.22
1.06
<0.01
0.29
0.54
<0.01
<0.01
19.8
0.07
0.06
0.23
2.01
1.69
0.21
<0.03
28.4
4.58
13.3
17.9
0.36
925
801
233
0.016
Liver
1'
41
1'1
0.002-0.012 0.036
0.008-0.042 0.128
e was cen- a liquid-gel partitioning technique
iin and the described previously (25). The gel with
lected in a incorporated lipophilic compounds was
action pro- poured into a glass column with an inner
hexane/2- diameter (ID) of2 cm (26) and the solvent
once with was drained. The gel was washed with 40
anic phases ml each ofmethanol-water 30:70 (v/v) and
pressure at 50:50 (v/v). The chlorinated compounds
i desiccator and some lipids were eluted with acetoni-
rature and trile (80 ml for liver samples and 110 ml
lissolved in for adipose tissue samples). Remaining
a 100-ml lipids were eluted with methanol/trichloro-
ining more methane/hexane (60 ml 1:1:1 by volume).
vith hexane The two fractions containing lipids were
as taken to taken to near dryness under reduced pres-
ame of the sure and dried to constant weight in a des-
i3 ml with iccator with silica gel. The sum of the
formic acid weights ofthe residues in the two fractions
imple solu- defined the amount oflipids in the sample.
(Packard Furtherpurification and separations.
L) (25) was MeSO2-CBs and MeSO2-DDEs were sepa-
npounds in rated from other organochlorine com-
Lipidex by pounds by adsorption chromatography
using 5% water-deactivated aluminium
from human oxide (5 g, 1 cm ID) (16). The fraction
containing PCBs and p,p'-DDE was
applied to activated silica gel (0.6 g, 0.5 cm
ID) (26) and subsequent determinations of
Range ppp'-DDE and CBs were made bygas chro-
0.02-0.15 matography (GC) electron-capture detec-
0.07-0.26 tion (Weistrand and Noren, unpublished
data). The fraction from the aluminium
0.03-0.10 oxide column, containing MeSO2-CBs and
<0.01-0.02 MeSO2-DDEs, was subjected to gel per-
0.03-0.16 meation chromatography (GPC) on Bio-
<0.01-0.07 Beads S-X3 (9 g, 1 cm ID; Bio-Rad
0.19-9.73 Laboratories, Richmond, CA) (17). After
0.61-2.61 concentration to approximately 50 pl, the
<0.01-0.02 fraction was injected into a 250 pl loop.
0.04-1.63 Hexane-dichloromethane (1:1 v/v) was
0.18-1.53 used as the mobile phase at a flow rate of
<0.01-0.55 1.0 ml/min. MeSO2-CBs and MeSO2-
<0.01 DDEs were collected between 22 min and 8.37-276 34 min. This fraction was concentrated to
<0.02-0.25w <0.02-0.25 approximately 50 pl and injected for a sec-
0.11-0.36 ond separation on the GPC system using
0.58-38.0 the same procedure. The fraction contain-
0.69-11.2 ing MeSO2-CBs and MeSO2-DDEs was
0.07-6.49 concentrated, an injection standard
<0.03 (2,2',3,3',4,4',5-heptaCB) was added, and
11.8-358 about half of the sample was analyzed by
0.41-31.1 gas chromatography-mass spectrometry
0.8847.1 (GC-MS) at a resolution of 5,000 (10%
0.32-1.15 valley definition), using electron ionization
and selected ion recording [for further 155-260652 details see Noren et al. (16)]. For each
11-612 compound, two ions in the molecular ion
0.005-0.033 cluster were monitored.
Preliminary study oftransfer into
0.015-0.175 Lipidex. Samples of human liver (-3 g) or
adipose tissue (-0.5 g) were fortified with
0.053-0.586 14C-cholesterol (2 pg, 33 nCi) or 14C_
phosphatidylcholine (0.2 pg, 25 nCi). The
samples were extracted as described using 5
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or 6 g Lipidex 5000 and with different
mixtures ofhexane, 2-propanol, and formic
acid. The gel with sorbed lipophilic com-
pounds was eluted with acetonitrile as
described above. The volumes of the frac-
tions from the Lipidex column were mea-
sured and 0.5 ml aliquots were taken for
determination ofradioactivity (24).
Results
In the preliminary study of transfer of
lipophilic compounds into Lipidex, the
recoveries of14C-cholesterol and 14C-phos-
phatidylcholine added to samples of adi-
pose tissue and liver from human subjects
prior to homogenization were 92-105%
and 97-98%, respectively.
The concentration of lipids in adipose
tissue and liver from the seven subjects
ranged from 52 to 99% and from 3 to 23%,
respectively. The recoveries of the internal
standard, MeSO2-IS, added to all samples
prior to homogenization ranged from 67 to
103% (mean 83%; n = 14). The recoveries
ofMeSO2-IS have been shown to correlate
well with the recoveries of MeSO2-CBs
(16,1?) and 3-MeSO2-DDE (16).
The concentrations ofMeSO2-CBs and
MeSO2-DDEs varied in the different sub-
jects (Table 1); therefore, mean values were
not calculated for the individual com-
pounds. However, the profiles of MeSO2-
CBs and MeSO2-DDEs (Figs. 1, 2, and 3)
were similar in all seven subjects.
In adipose tissue and liver, most of the
penta- and hexachloro-substituted con-
geners were found at higher concentrations
than the other MeSO2-CBs (Table 1, Fig.
1). In adipose tissue, the pentaCB methyl
sulfone 4-87 and the hexachloro compound
4-149 were found at highest concentrations
(Fig. 2). In the liver, compound 3-132 was
found at a higher concentration than any of
the other aryl methyl sulfones; the contri-
bution of this compound to the sum of
MeSO2-CBs ranged from 61% to 82% in
the individual samples. In adipose tissue,
the concentration of 3-132 was low, only
0-4% of the sum of MeSO2-CBs. In the
liver, the sum of3-MeSO2-CBs was higher
than the sum of4-MeSO2-CBs. The ratios
ofthe sums of3-MeSO2-CBs to 4-MeSO2-
CBs ranged from 4 to 21 in the liver sam-
ples. Only compounds 4-49, 4-87, 4-101,
and 4-141 were found at higher concentra-
tions than the corresponding 3-MeSO2-
substituted congeners. In adipose tissue, the
ratios of the sums of 3-MeSO2-CB to 4-
MeSO2-CBs were below 1 (0.2-0.5) in all
subjects, and only compounds 3-64, 3-70,
and 3-174 were found in larger amounts
than the corresponding 4-MeSO2-CBs.
The sum of the determined CBs was
similar in adipose tissue and liver in paired
19.5
3
I, 2 42
._
a
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Figure 1. Concentrations of MeSO2-CBs (for structures see Table 1), 2-MeSO2-DDE (2-DDE), and 3-
MeSO2-DDE (3-DDE) in human adipose tissue and liver (74year-old man).
samples (Weistrand and Noren, unpub-
lished data). In contrast, the sum ofthe con-
centrations ofMeSO2-CBs was significantly
higher in the liver than in adipose tissue in
all cases. The ratios ofthe sum MeSO2-CBs
to the sum of CBs were 8-34 times higher
in the liver than in adipose tissue as calculat-
ed from the individual values.
Two methyl sulfone metabolites ofp,p'-
DDE were found in the samples (Figs. 1, 3,
Table 1). We lacked authentic 2-MeSO2-
DDE, but comparison with studies where
this compound has been identified (6) sug-
gests that the peak appearing ahead of 3-
MeSO2-DDE in the selected ion current
chromatogram represents 2-MeSO2-DDE
(Fig. 3). Assuming that 2-MeSO2-DDE has
the same response as 3-MeSO2-DDE, the
concentrations of 2-MeSO2-DDE were
lower than those of 3-MeSO2-DDE in all
samples, except in the liver sample from one
of the female subjects (47 years old). The
ratios of 2-MeSO2-DDE to 3-MeSO2-
DDEs were about 10 times higher in liver
than in adipose tissue (Table 1).
The concentrations ofp,p'-DDE were
similar in liver and adipose tissue in the
individual subjects. The concentrations of
the methyl sulfone metabolites ofp,p'-DDE
were higher in liver than in adipose tissue in
all individuals. The ratios of the sum of
MeSO2-DDEs to p,p'-DDE were 2-28
times higher in the liver than in adipose tis-
sue as calculated from individualvalues.
In addition, a sample oflung tissue (2 g)
was collected from one ofthe male subjects
(68 years old) and was treated and analyzed
using the same procedure as described for
the liver samples. The ratios ofthe sum of
MeSO2-CBs and MeSO2-DDEs to the
sum of CBs and p,p'-DDE, respectively,
were very similar in lung and adipose tissue
from this individual. Also, the profile of
MeSO2-CBs and MeSO2-DDEs in lung
resembled the profile of these compounds
in adipose tissue. However, 2-MeSO2-
DDE was not detected in the lung.
Discussion
In a previous study using Lipidex for
extraction of PCBs and lipids in fish oil
(25), the lipids mainly consisted of triacyl-
glycerols. To validate the method for cho-
lesterol and more polar phospholipids
occurring in the liver, recovery studies were
performed with 14C-cholesterol and '4C-
phosphatidylcholine added to liver and adi-
pose tissue from human subjects. Slight
modifications ofthe previous method were
made to achieve satisfactory recoveries. The
ratio ofhexane to 2-propanol was changed,
formic acid added, and the amount of
Lipidex increased.
In the present study, most ofthe investi-
gated MeSO2-CBs (Table 1) were found in
human adipose tissue and liver. However,
most of the parent compounds to these
MeSO2-CBs were belowthe detection limits
in the tissues. Only low levels were found of
2,2',5,5'-tetraCB (CB-52), 2,2',4,5,5'-
pentaCB (CB-101), and 2,2',3,3',4,5,6'-
heptaCB (CB-174).
In adipose tissue, most of the 4-
MeSO2-CBs were present at higher concen-
trations than the corresponding 3-MeSO2-
CBs; congeners 4-87 and 4-149 were found
at the highest concentrations. These were
also the major congeners in Swedish human
milk (16) and blood plasma (17). In addi-
tion, the concentration ratios of MeSO2-
CBs to CB-153, which is a stable and pre-
dominant CB in mammals, were similar in
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three chlorine ato
2.7E6 the corresponding 4-MeSO2-CB was also
found at high concentrations (6). A similar
2.1E6 profile has been found in polar bear fat from
1.E E |_11* _Canada, but 3-87 and 4-87 were also found
at high concentrations (6,24. In livers from
i.1E8 l lSwedishwildanimals(greyseal, otter, mink) 116 g 11 lIIIand Canadian polar bears, 3-149 and 3-87
5.3E5 were the most abundant MeSO2-CBs,
respectively (6,28). The different pattern of
i.OEO MeSO2-CBs indicate differences in exposure
18:00 19:00 20:00 21:00 22:00 23:00 and/or metabolism ofCBs.
7.E6 Toxicological studies of MeSO2-CBs
5.9E6 have indicated that compounds 3-49, 3-87,
and 3-101 were, ofthe tested MeSO2-CBs,
4.4E6 the most potent inducers of certain hepatic
enzymes (29). Compound 3-132, which was
3.0E6 found at high concentrations in the present
__E_ investigation ofhuman liver, was shown to
__1.5E6 be aweak inducerofthese enzymes (29).
_.OEO & The retention ofcertain 3-MeSO2-CBs
18:00 19:00 20:00 21:00 22:W0 23:00 ' in livers of wild mammals (6,28) and in
2.8E6 humans indicates that MeSO -CBs with - _ 28E6 ~ ~ ~~~~~~~~~~- suhsrcre ar ,2, such structures are noncovalently bound in
2.2E6 the liver, probably to proteins. Such bind-
ing has been described between certain 4-
1.7E6 MeSO2-CBs and a uteroglobin-type pro-
tein (12) and a fatty acid binding protein
1.1E6 (FABP) (30-32). In addition, it has been
5.5E5__ _ shown that a 3-MeSO2-CB (3-101) binds
X_ s _ s ~~~~~~~ ~ ~~~~~~~~~~~~~~5.5E5. to FABP (rat liver) (32).
O.OEO Two MeSO2-DDEs were identified in
18:00 19:00 20:00 21:00 22:00 23:00 the adipose tissue and liversamples from the
4.4E7 Swedish subjects. Both in adipose tissue and
3__ _ _ _ liver, 3-MeSO2-DDE was found at higher
3.5E7 concentrations than 2-MeSO2-DDE. In
UP8E7 adipose tissue, 3-MeSO2-DDE was the pre-
dominant aryl methyl sulfone and 2-
18E7 MeSO2-DDE was only found at low con-
centrations, about 1/20 ofthe concentration
8.8E6 of3-MeSO2-DDE. Low levels of2-MeSO2-
DDE were also found in Swedish human
O.OEO milk (16) and inJapanese adipose tissue and
18:00 19:00 20:00 21:00 22:00 23:00 liver (7). In the Swedish liver samples, 3-
Time(min) MeSO2-DDE was one of the most abun-
dant aryl methyl sulfones, but it was found
In current chromatograms of MeSO -CBs in human adipose tissue and liver. atlowe cetrations t 3-Mwsou- 2 at lower concentrations than 3-MeSO2-
2,2',3',4',5,6-hexaCB (3-132). 2-MeSO2-
e samples (0.008-0.042), GC-MS analyses ofadipose tissue and liver DDE was the third most abundant aryl
nilk (0.02-0.04) (16), and from the Swedish subjects. Compound 3- methyl sulfone and was found at about one-
)02-0.03) (17). 132 was by far the predominant MeSO2-CB third of the concentration of 3-MeSO2-
of MeSO2-CBs in the in the liver samples from Swedish subjects; DDE. The sum of the concentrations of
(human milk, blood plas- also, most ofthe other identified 3-MeSO2- MeSO2-DDEs and the ratio of2-MeSO2-
, lung, liver) differed from CBs were found at higher concentrations DDE to 3-MeSO2-DDE were higher in the
se investigation (7). In the than the corresponding 4-MeSO2-CBs in liver than in adipose tissue, which indicates
4-87 was the most abun- this tissue. The differences between the selective binding in the liver. In wild mam-
in adipose and lung tissue Japanese and Swedish profiles ofMeSO2- mals, the ratio of 2-MeSO2-DDE to 3-
ient, but not in the samples CBs may be due to different sources ofexpo- MeSO2-DDE in these tissues, has been
ubject. 4-MeSO2-2,4',5- sureand/ormetabolismofCBs. found to vary with species and tissue, and
st abundant MeSO2-CB in The profiles ofMeSO2-CBs in wild ani- the results indicate differences in exposure
n the control subject, while mals differ from those in humans and have and/or metabolism ofDDT/DDE (6).
triCB was found at highest also been found to vary in differer
the liver from this individ- species (6). In muscle or blubb
t, MeSO2-CBs with two or Swedish wildlife (otter, mink, grey
ims were not found in the 101 was the predominant MeSO2.
nt animal
zer from
r seal), 3-
-CB, but
Conclusions
In the present study, MeSO2-CBs and
MeSO2-DDEs were determined together
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Figure 3. Selected ion current chromatograms of MeSO2-DDEs in human adipose tissue and liver.
with CBs and p,p'-DDE in tissues from
seven Swedish human subjects. MeSO2-
CBs and MeSO2-DDEs were found in all
samples showing a general occurrence of
these metabolites together with CBs and
p,p'-DDE. The profiles ofMeSO2-CBs and
MeSO2-DDEs were similar in adipose tis-
sue and lung. A different pattern was found
in the liver. The concentrations of CBs
were similar in adipose tissue and the liver.
This was also the case for p,p'-DDE.
However, the methyl sulfonyl metabolites
ofthese compounds were significantly high-
er in liver than in adipose tissue (lipid
weight basis). In the human liver, 3-
MeSO2-2,2',3',4',5,6-hexaCB (3-132) was
by far the predominant MeSO2-CB.
Certain 3-MeSO2-CBs have previously
been found to be selectively retained in the
livers ofdifferent wild mammals. This indi-
cates that certain structures of MeSO2-CBs
facilitate noncovalent binding in the liver,
most probably to proteins. Also, the
metabolites may have toxic effects.
However, little is known about the toxicity
and possible effects in humans; therefore
this subject requires further study.
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*Management, organization, and control in the field ofsafety and health in
the workplace (programs, risk analysis, assessment, normalization, quality...)
*Specific problems ofoccupational safety and health in small- and medium-
sized enterprises as well as possibilities for counseling and support
*Current problems of occupational hygiene (dust, mineral fibers,surface
treatments)
Furthermore,the symposium will discuss other current problems and solu-
tions, such as the transposition of European Directives or outsourcing.
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